BRISBANE, Australia, Sept. 12, 2024 /PRNewswire/ — White Rook Cyber is excited to announce they have strategically merged with the privately owned Screwloose IT (SL). The merger of White Rook Cyber, a premium industry leader in Cyber Security, Offensive Security (including penetration testing and technical security) and GRC Advisory Services (including compliance auditing and technical […]
Category Archives: Pr Newswire
MONTREAL and CAMPBELL, Calif., Sept. 12, 2024 /PRNewswire/ — From ALL IN 2024: WEKA, the AI-native data platform company, and S&P Global Market Intelligence unveiled the findings of their second annual Global Trends in AI report. The global study, conducted by S&P Global Market Intelligence and commissioned by WEKA, surveyed over 1500 AI practitioners and decision-makers to […]
LISHUI, China, Sept. 12, 2024 /PRNewswire/ — CN Energy Group. Inc. (the “Company”; NASDAQ: CNEY), today announced that on September 6, 2024, the Company received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is currently not in compliance with certain requirements under the relevant Nasdaq […]
PONTE VEDRA, Fla., Sept. 11, 2024 (GLOBE NEWSWIRE) — Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship Lapiplasty® and Adductoplasty® Procedures, today announced it will highlight new product innovations and present new interim data for the […]
SOUTH SAN FRANCISCO, Calif., Sept. 11, 2024 (GLOBE NEWSWIRE) — Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced that it will host a Research Forum to highlight its pipeline of next-generation ADCs. The live webcast will be held on Thursday, […]
Boston (September 11, 2024) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a clinical-stage pharmaceutical company dedicated to developing personalized cancer treatments, today announced that the Company is taking a decisive step toward regaining compliance with Nasdaq’s listing requirements, as outlined by the Nasdaq Hearings Panel during a meeting on August 15, 2024. […]
Contributing Funding and a Significant Additional Tool to Combat PTSD and TBI JACKSON CENTER, Pa., Sept. 11, 2024 (GLOBE NEWSWIRE) — Halberd Corporation (OTC PINK: HALB), in coordination with Athena Telemedicine Partners (ATP) and Athena GTX, Inc., is pleased to announce a substantial contract award commitment. Defense Atomics Corporation agreed to engage with the Halberd/Athena […]
NEW YORK, Sept. 11, 2024 (GLOBE NEWSWIRE) — Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company dedicated to improving the lives of people affected by rare epilepsies and brain conditions, today announced the promotion of Meg Alexander to President and Chief Operating Officer (COO). Alexander will work in collaboration with Ovid’s leadership team to advance […]
PARIS, Sept. 11, 2024 /PRNewswire/ — Huawei announced the implementation stage of the Technology-enabled Open Schools for All Phase II project in Brazil, Egypt, and Thailand at Digital Learning Week, UNESCO’s flagship event on digital learning and the transformation of education. Attendees at the UNESCO-Huawei Technology-enabled Open Schools for All Forum / Image Credit © […]
SEOUL, South Korea, Sept. 11, 2024 /PRNewswire/ — Hyosung Chairman Cho Hyun-joon is fostering Vietnam as Hyosung’s global strategic base through continuous investment. Since Hyosung first moved to Vietnam in 2007, it has been growing together with the Vietnamese economy. Hyosung has invested a total of $3.5 billion and established approximately six production subsidiaries across […]
